British Dragon
British Dragon
Andropen 450 mg
Product Information Compound Details
Active Formula Testosterone Blend
450 mg/mLTestosterone Acetate 32 mg
Testosterone Propionate 73 mg
Testosterone Phenylpropionate 73 mg
Testosterone Cypionate 125 mg
Testosterone Decanoate 147 mg
Total Strength 450 mg/mL
Package 10 mL Vial 4,500 mg Total Labeled Content
Form Oil-Based Injectable
Formula 5-Ester Testosterone Blend
Drug Class Anabolic-Androgenic Steroid
Manufacturer British Dragon
Shipping :
International
U.S. Domestic
Out of stock
- Overview
- Profile
- Usage
- Safety
- Shipping
- Storage
- FAQ
- Reviews
Product Overview
Andropen 450 mg by British Dragon
Andropen 450 mg is an oil-based injectable testosterone blend manufactured by British Dragon containing five testosterone esters at a total concentration of 450 mg/mL in a 10 mL vial.
Testosterone Blend Injectable
Andropen 450 mg is an injectable anabolic-androgenic steroid combining five distinct testosterone esters: acetate, propionate, phenylpropionate, cypionate, and decanoate. This multi-ester design is intended to provide both rapid onset from the short-chain esters and prolonged activity from the longer-chain esters, creating a release profile that spans from hours to weeks after a single injection.
In clinical practice, testosterone replacement therapy is the established medical use for testosterone esters, indicated for appropriately diagnosed hypogonadism. The Endocrine Society guideline recommends testosterone therapy in hypogonadal men to induce and maintain secondary sex characteristics and correct symptoms of testosterone deficiency. However, Andropen 450 specifically is a blend formulation that does not have its own FDA approval; it is a non-pharmaceutical product marketed for research purposes.
In non-medical bodybuilding contexts, multi-ester testosterone blends like Andropen 450 are commonly referenced as a base compound for bulking cycles, with users reporting both rapid strength increases and sustained anabolic effects from the combined ester profile. The 450 mg/mL concentration is significantly higher than standard single-ester testosterone products, which typically range from 100 to 250 mg/mL. Such use falls outside approved indications and carries the full spectrum of androgen-related risks.
Key Properties of Andropen 450 mg
- Five-ester testosterone blend for rapid onset and extended release
- High concentration of 450 mg/mL per vial
- Combines acetate, propionate, phenylpropionate, cypionate, and decanoate esters
- MCT oil formulation for smooth injection characteristics
- 10 mL vial provides 4,500 mg total labeled content
Carrier Oil
MCT Oil Formulation
Andropen 450 mg uses MCT oil as its carrier oil, providing the oil base for the five-ester testosterone blend. MCT oil is a commonly used carrier in injectable anabolic preparations, chosen for its low viscosity and compatibility with esterified compounds.
Product Profile
Testosterone Blend Profile
Andropen 450 is a multi-ester testosterone preparation designed to combine fast-acting and long-acting release profiles in a single injection.
Five-Ester Testosterone Blend
The pharmacological rationale behind a multi-ester blend is to achieve a release profile that cannot be obtained from a single ester. Testosterone acetate and propionate are short-chain esters that release testosterone within hours to a few days. Testosterone phenylpropionate and cypionate occupy an intermediate range, while testosterone decanoate provides the longest duration of activity, releasing over a period of weeks.
Each ester is formed by attaching a fatty acid chain to the 17β-hydroxyl group of testosterone. The length and structure of this chain determine the compound's lipophilicity and, consequently, how quickly it is absorbed from the injection depot and hydrolyzed to free testosterone. Shorter chains (acetate, propionate) are absorbed and cleaved more rapidly; longer chains (cypionate, decanoate) are absorbed more slowly and sustain testosterone release for extended periods.
In non-medical contexts, the combined ester profile is commonly referenced as providing both a rapid "kick" from the short esters and a sustained baseline from the long esters, potentially reducing the frequency of injection compared to single short-ester products.
Release Profile
Multi-Phase Testosterone Release
Andropen 450's five esters create a release curve that begins within hours (acetate), peaks in the first few days (propionate, phenylpropionate), and continues for two to three weeks (cypionate, decanoate). This profile distinguishes it from single-ester products such as Testabol Depot (cypionate) or Testabol Propionate.
Andropen 450 mg vs Other British Dragon Testosterone Preparations
British Dragon offers several single-ester testosterone formulations that provide reference points for comparison. Testabol Depot contains testosterone cypionate at 250 mg/mL, a long-acting ester with a half-life of approximately 8 days. Testabol Enanthate offers testosterone enanthate at 250 mg/mL with similar release characteristics. Testabol Propionate contains the short-acting propionate ester at 100 mg/mL, requiring frequent administration. Andropen 450's distinguishing feature is its combination of all these release profiles in a single, higher-concentration preparation.
Dosage & Usage
Andropen 450 mg Dosage & Usage
The information below is provided for educational reference only. Testosterone is a prescription androgen; medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring. Non-medical use falls outside approved indications.
Typical Dosage Ranges
In medically supervised testosterone replacement therapy, dosing is individualized based on laboratory results and clinical response. The FDA label for testosterone cypionate injection, a representative long-acting ester, recommends 50 mg to 400 mg administered every two to four weeks as a deep intramuscular injection.
In non-medical bodybuilding contexts, multi-ester testosterone blends such as Andropen 450 are commonly referenced at 450 to 900 mg per week, administered in two or three divided injections. Community discussions describe users splitting the weekly dose across multiple injection days to manage the short-ester component and maintain stable blood levels. The high concentration of 450 mg/mL means that a single milliliter provides a substantial dose, and users frequently reference 0.5 mL to 1 mL per injection.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| TRT (medical, single ester reference) | 50–400 mg per 2–4 weeks | Every 2–4 weeks |
| Non-medical (reported) | 450–900 mg/week | 2–3 times weekly |
| Conservative non-medical (reported) | 450 mg/week | 2 injections weekly |
These non-medical ranges represent community-reported practices and are not derived from controlled clinical trials for performance enhancement. The multi-ester composition means that the effective half-life of the blend is a composite of the individual esters, and users commonly reference a two- to three-day injection frequency to manage the short-ester components.
Stacking & Cycle Considerations
In non-medical bodybuilding contexts, multi-ester testosterone blends are frequently used as a base compound in bulking cycles and may be combined with other injectable or oral compounds. British Dragon offers several products commonly referenced in this context, including Decabol 250 (nandrolone decanoate) for joint support and mass, and Methanabol (methandienone) as an oral kick-start.
Cycle structure, duration, and support compounds should be considered in the context of individual experience, health status, and bloodwork where possible. The high concentration of Andropen 450 means that careful attention to volume per injection site is warranted to minimize discomfort.
Managing Side Effects
Testosterone aromatizes to estrogen, which can contribute to water retention, gynecomastia, and elevated blood pressure in susceptible individuals. Aromatase inhibitors such as Anastrozole or Exemestane are commonly referenced in non-medical contexts to manage estrogenic side effects, though use should be based on individual response and bloodwork where possible.
Other potential adverse effects of testosterone therapy include polycythemia (increased red blood cell production), injection site reactions, and suppression of endogenous testosterone production. Cholesterol and hematocrit levels should be monitored during use.
Post-Cycle Therapy (PCT)
After completing a cycle with Andropen 450, post-cycle therapy is commonly referenced to help restore endogenous testosterone production and support hormonal recovery. Agents such as Clomiphene or Tamoxifen are commonly referenced for this purpose.
PCT protocols vary based on cycle length, compounds used, and individual factors. Bloodwork and, where possible, medical guidance can help inform recovery strategy. The decanoate ester in Andropen 450 has a particularly long clearance time, meaning that PCT timing should account for the extended presence of the longest ester.
Important
Individual Response Varies
Dosing strategies, support compounds, and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Safety & Information
Testosterone Blend Safety Information
Andropen 450 contains testosterone, a Schedule III controlled substance. It is not approved for athletic performance enhancement and carries significant cardiovascular, hepatic, and endocrine risks.
Important Safety Information
The FDA has explicitly stated that testosterone cypionate has not been shown to be safe and effective for the enhancement of athletic performance, and because of the potential risk of serious adverse health effects, this drug should not be used for such purpose. The Endocrine Society recommends against testosterone therapy in men planning fertility in the near term or in men with breast or prostate cancer, elevated hematocrit, untreated severe obstructive sleep apnea, uncontrolled heart failure, myocardial infarction or stroke within the last 6 months, or thrombophilia.
Testosterone is contraindicated in pregnancy and is not indicated for use in females. Exposure of a female fetus to androgens may result in varying degrees of virilization.
Important
Non-Medical Testosterone Use
Higher-than-physiologic testosterone exposure can carry additional health risks. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual.
Potential Adverse Effects
Testosterone therapy can increase red blood cell production and hematocrit (polycythemia). Excessive elevation can require medical evaluation and changes to treatment. Cardiovascular adverse effects include myocardial infarction, stroke, and venous thromboembolism.
Testosterone can suppress spermatogenesis through feedback inhibition of the hypothalamic-pituitary-testicular axis. Reduced fertility is observed in some men, and the impact may be irreversible. Testicular atrophy, subfertility, and infertility have been reported in men who abuse anabolic androgenic steroids.
Other potential androgen-related effects include acne, changes in skin oil production, fluid retention, gynecomastia, and changes in prostate-related symptoms. The Endocrine Society notes that long-term safety, particularly regarding prostate cancer, remains unclear.
Conditions Requiring Medical Evaluation
Testosterone therapy is not appropriate for everyone. Medical guidelines identify circumstances in which treatment should be avoided or carefully evaluated, including known or suspected prostate or male breast cancer, elevated hematocrit, untreated severe obstructive sleep apnea, certain cardiovascular conditions, thrombophilia, and near-term fertility plans.
Geriatric patients treated with androgens may be at increased risk of developing prostatic hypertrophy and prostatic carcinoma.
Monitoring During Therapy
Medically supervised testosterone therapy typically involves follow-up assessment to evaluate treatment response, adverse effects, and relevant laboratory markers. Hemoglobin and hematocrit levels should be checked periodically to detect polycythemia. Serum cholesterol may increase during androgen therapy.
The Endocrine Society recommends monitoring men during the first year of treatment and annually thereafter. Prostate cancer risk should be assessed before starting testosterone treatment and 3 to 12 months after starting.
Product Care
Storage & Handling
Store at controlled room temperature (20° to 25°C / 68° to 77°F). Protect from excessive heat, moisture, and direct light. Do not freeze. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated, or otherwise abnormal. Keep out of reach of children.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
Andropen 450 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Andropen 450 mg product, use the security code on the vial label and cross-check it on the British Dragon official site. Official British Dragon presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Andropen 450 mg Storage
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Recommended Conditions
Store at controlled room temperature (20° to 25°C / 68° to 77°F). Protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oil-based formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Quick Reference
Do & Don't
- Do store at 20–25°C
- Do keep in original packaging
- Do inspect before each use
- Don't freeze the vial
- Don't expose to direct sunlight
- Don't use if solution looks abnormal
Frequently Asked Questions
Andropen 450 mg FAQ
Answers to common questions about Andropen 450 mg, the testosterone blend, release characteristics, product strength, and related topics.
What is Andropen 450 mg used for?
Andropen 450 mg contains a blend of five testosterone esters. In medical practice, testosterone esters are used for testosterone replacement therapy in appropriately diagnosed hypogonadism. In non-medical bodybuilding settings, multi-ester testosterone blends are commonly referenced as a base compound for muscle growth, strength, and recovery, though such use falls outside approved medical indications and the FDA has stated that testosterone should not be used for athletic performance enhancement.
How often should Andropen 450 mg be injected?
The multi-ester composition of Andropen 450 means the release profile is a composite of five different esters. In non-medical community discussions, users commonly reference injecting two to three times per week to manage the short-ester components. In medically supervised testosterone replacement therapy, injection frequency is individualized by a clinician based on the specific ester and laboratory results.
Does Andropen 450 mg require PCT?
Testosterone suppresses endogenous testosterone production through feedback inhibition of the hypothalamic-pituitary-testicular axis. In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a testosterone cycle to help restore natural testosterone production. Agents such as Clomiphene or Tamoxifen are commonly referenced for this purpose.
What does the testosterone blend in Andropen 450 do?
Testosterone exerts its effects by activation of the androgen receptor, either directly or after conversion to dihydrotestosterone (DHT), and by conversion to estradiol and activation of certain estrogen receptors. These effects include the growth and maintenance of male sex organs and secondary sex characteristics, as well as alterations in body musculature and fat distribution.
How long does Andropen 450 take to work?
The acetate and propionate esters in Andropen 450 release testosterone relatively quickly, with effects potentially noticeable within days to the first week. The longer esters (cypionate, decanoate) provide sustained release over two to three weeks. In non-medical contexts, users commonly report beginning to notice effects within the first one to two weeks of use.
Is Andropen 450 the best testosterone?
There is no single testosterone ester or blend that is universally best. The appropriate choice depends on the specific use case, desired release profile, and individual factors. Single-ester products such as Testabol Depot (cypionate) or Testabol Propionate offer simpler pharmacokinetics. Andropen 450's distinguishing characteristic is its combination of five esters in a high-concentration formulation.
What is the difference between Andropen 450 and Sustanon?
Both Andropen 450 and Sustanon are multi-ester testosterone blends, but they differ in ester composition and concentration. Andropen 450 contains testosterone acetate, propionate, phenylpropionate, cypionate, and decanoate at a total of 450 mg/mL. Sustabol 350 is a comparable British Dragon product with a different ester mix at 350 mg/mL. The specific ester composition affects the release curve and injection frequency considerations.
What is the difference between Andropen 450 and Testabol Depot?
Andropen 450 is a multi-ester blend, while Testabol Depot contains only testosterone cypionate, a single long-acting ester. The cypionate ester has a half-life of approximately 8 days, providing a slower and steadier release profile. Andropen 450 combines this with shorter esters for a more complex release curve that begins more rapidly after injection.
Is 450 mg of Andropen a lot?
Andropen 450 is labeled at 450 mg of testosterone blend per mL. This is a high concentration compared to standard single-ester testosterone products, which typically range from 100 to 250 mg/mL. The FDA label for testosterone cypionate injection recommends 50 mg to 400 mg every two to four weeks for replacement therapy. A single milliliter of Andropen 450 exceeds that range for a single injection.
What strength is Andropen 450 mg?
Andropen 450 mg is labeled at 450 mg of total testosterone esters per mL. It is supplied in a 10 mL vial, giving 4,500 mg of total labeled testosterone content per vial. The blend contains testosterone acetate 32 mg, propionate 73 mg, phenylpropionate 73 mg, cypionate 125 mg, and decanoate 147 mg.
Is Andropen 450 lab tested?
No lab reports were provided for this specific product listing. For products with published laboratory reports, those results would apply to the specific tested sample and should not be interpreted as a measurement of every vial or production batch.
Related Offers
British Dragon Pharmaceuticals
Product Information
Compound Details
Active Substance
Nandrolone Decanoate
Long-Acting 19-Nor Anabolic-Androgenic Steroid
250 mg/mL
Strength
250 mg/mL
Package
10 mL Vial
2,500 mg Total Labeled Content
Form
Oil-Based Injectable
Drug Class
Anabolic-Androgenic Steroid
Estimated Half-Life
Approximately 6–12 Days
Manufacturer
British Dragon
British Dragon Pharmaceuticals
Product Information
Compound Details
Active Substance
Methandienone
Dianabol · 17α-Alkylated Oral Anabolic Steroid
10 / 20 / 50 mg
Strength
10, 20, or 50 mg/tablet
Package
100 Tablets
Form
Oral Tablets
Drug Class
Anabolic-Androgenic Steroid
Estimated Half-Life
Approximately 3–6 Hours
Manufacturer
British Dragon
Lab Tested
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance Testosterone Cypionate Long-acting testosterone ester
250 mg/mLStrength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable
Estimated Half-Life Approximately 8 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer British Dragon
British Dragon Pharmaceuticals
Product Information Compound Details
Active Formula Testosterone Blend
350 mg/mLTestosterone Propionate 42 mg
Testosterone Isocaproate 84 mg
Testosterone Phenylpropionate 84 mg
Testosterone Decanoate 140 mg
Total Strength 350 mg/mL
Package 10 mL Vial 3,500 mg total labeled content
Form Oil-Based Injectable
Formula 4-Ester Testosterone Blend
Drug Class Androgen & Anabolic Steroid
Manufacturer British Dragon